CKDXF — Opthea Ltd
—
OTC ·
Health Care ·
Biotechnology ·
CIK 1815620 ·
Australia
Last close
$0.01
Market Cap
$13.68M
52W High
$0.44
52W Low
$0.01
ADV30
0
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Dec 2024 | — | — | — | — | 145,770,000 | 131,916,000 | 314,475,000 |
| Sep 2024 | — | — | — | — | — | — | — |
Balance + Analyst (yfinance extras)
Retained Earnings
$-711,622,000
Inventory
—
Receivables
$7,984,000
ST Investments
—
EBIT TTM
—
Pretax Income TTM
—
Interest Exp TTM
—
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$-20,117
EBITDA
$-109,394,000
Free Cash Flow
$-217,397,456
Enterprise Value
$-19,488,218
Total Cash
$33,168,000
Total Debt
$0
Shares Out
1,367,978,173
Trailing EPS
$-0.01
Book Value
$0.02
ROE
—
ROA
-50.4%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Jun 2025 | 25,000 | -152,312,000 | -162,791,000 | 56,799,000 | 257,868,000 | — | — |
| Jun 2024 | 125,000 | -191,842,000 | -220,242,000 | 188,791,000 | 264,601,000 | — | -161,015,354 |
| Jun 2023 | 108,000 | -150,025,000 | -142,521,000 | 98,641,319 | 104,494,497 | — | -120,608,379 |
| Jun 2022 | 90,683 | -96,537,963 | -92,817,371 | 60,046,819 | 12,069,675 | — | -71,334,952 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| PASG | Passage BIO, Inc. | $14.36M | $4.47 | — |
| BCDA | BioCardia, Inc. | $12.21M | $0.82 | — |
| ZIVO | Zivo Bioscience, Inc. | $16.61M | $4.00 | — |
| INTS | INTENSITY THERAPEUTICS, INC. | $11.22M | $4.15 | — |
| PLUR | Pluri Inc. | $16.72M | $1.55 | — |
News headlines (Yahoo Finance, 1h cache)
Recent Insider Activity
No insider activity indexed for this ticker.